NRG1 and breast carcinoma: However, unlike breast cancer cells, this was independent of NRG1-ERBB3 signaling because co-treatment with INK128 combined with ERBB3 inhibitor MM-121 also showed increased pAkt T308, similar to INK128 alone (Fig. 3C).